...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Re: 50/50 at best on Zen being sold this year IMO..

 "To be fair, if i do not like your offer, i should have the opportuity to sell my certificates to you for the same price you offered yours to me. Zenith does need money, considerably more than 2 mil."

other than humility or lack there of, ignorance & arrogance are also undesirable traits that sometime stem from CEO's & insiders.

Share
New Message
Please login to post a reply